Module VII: Philip Kantoff, MD
Module VI: A Oliver Sartor, MD
Module V: Howard Sandler, MD, MS
Module IV: Matthew R Smith, MD, PhD
Module V: Dr Howard Sandler
Contact Form | App support
Please describe your issue and we will contact you.
ASH2 FL Poster
Tolerance and Response to Initial Systemic Therapy in Younger and Older Patients with Follicular Lymphoma: A Cross-Sectional Case Survey with 186 Unselected Recent Cases in the Practices of US-Based Medical Oncologists
N Love, MD; S Gregory, MD; B Cheson, MD; M Czuczman, MD; K Ziel, PhD; M Elder, BBA; D Paley, BA; A Asnis-Alibozek, MPAS, PA-C
Use of Bisphosphonates by US-Based Community Oncologists — 2009 National Patterns of Care Survey in Breast Cancer
Use of Bisphosphonates by US-Based Community Oncologists — 2009 National Patterns of Care Survey in Breast Cancer
5-Minute Journal Club — SABCS 2010 Presentations
Please click each issue for edition topic links.
San Antonio Highlights: When Should Patients with Metastatic Breast Cancer Be Rebiopsied? And More... Issue 8 — March 21, 2011 — Current Edition
Lenalidomide with Low- or High-Dose Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma (MM)
Bortezomib-Based Maintenance Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma (MM)
Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (MM) or MM in the Post-Transplant Setting
Carfilzomib/Lenalidomide/Dexamethasone (CRd) as Initial Therapy for Patients with Newly Diagnosed Multiple Myeloma (MM)
5-Minute Journal Club — ASH 2010 Presentations
ASH Highlights: MDS 2011 — The Future Ain't What It Used to Be
Issue 8 — March 29, 2011 — Current Edition
Tolerance and Response to Initial Systemic Therapy in Younger and Older Patients with Multiple Myeloma: A Cross-Sectional Case Survey with 276 Unselected Recent Cases in the Practices of US-Based Medical Oncologists
Tolerance and Response to Initial Systemic Therapy in Younger and Older Patients with Multiple Myeloma: A Cross-Sectional Case Survey with 276 Unselected Recent Cases in the Practices of US-Based Medical Oncologists.
N Love, MD; S Lonial, MD; K Anderson, MD; R Fonseca, MD; K Ziel, PhD; M Elder, BBA; D Paley, BA; A Asnis-Alibozek, MPAS, PA-C